Clinical Trial Update: Study of NSI-189 for Major Depressive Disorder [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for NSI-189 in Major Depressive Disorder; the current status of the study is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• NSI-189 (NSI-189)

Snippet

Sponsor: Neuralstem Inc. | Conditions: Major Depressive Disorder | Phase 2 | Status: UNKNOWN